Stopcap M1
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
90 High Holborn Fl 2, London, Greater Lo...Website
www.stopcapm1.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
About Stopcap M1
Stopcap M1 Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Stopcap M1 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Stopcap M1 had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Stopcap M1
Stopcap M1, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Stopcap M1 launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Stopcap M1 is spiking on competitors!
Check if Stopcap M1 has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Stopcap M1 recently announced quarterly report
Funding: Get notified immidiatlly once Stopcap M1 has new funding data
Recommended Actions
Find VP level buyers at Stopcap M1
Find 2 more new buyers
Stopcap M1 Tech Stack
A closer look at the technologies used by Stopcap M1
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stopcap M1
STOPCAP is a collaborative initiative focused on systematic reviews and clinical trials related to prostate cancer treatments, including drugs like Docetaxel, Zoledronic acid, and Abiraterone. The organization aims to improve patient outcomes through the FAME approach and the collection of surrogate outcomes. Their intended clients include healthca... Read More
